Literature DB >> 6860147

Anti M-protein antibody response to type A or B natural influenza detected by solid phase enzyme linked immunosorbent assay and by complement fixation.

L Joassin, M Reginster, D Vaira.   

Abstract

Anti M-protein antibody response has been looked for in sera from individuals with serological evidence of A or B influenza infection using pure M-protein (M) in complement fixation tests (CF), in IgG and in IgA specific enzyme linked immunosorbent assays (ELISA). Mp ELISA (IgG specific) antibodies are not restricted to people with history of recent respiratory infection. Individuals under 15 years are less prone than those older to display M ELISA activity. Most M ELISA positive individuals are also nucleoprotein (NP) positive. There are more M than NP ELISA positives in the influenza A series whereas the reverse is observed in the influenza B series. Most of the M ELISA positives are also S CF (standard soluble antigen CF) positive indicating that M ELISA IgGs are related to recent infections. Some sera exhibit M ELISA activity with no other evidence of influenza experience than V CF (viral antigen CF) or HI (haemagglutination inhibition), suggesting that some recent influenza infections are better traced with M ELISA than with S CF. Amongst chronic bronchitis patients with V CF or HI antibodies to A2 influenza virus but no type A S CF activity, the proportion of M ELISA positives averages 40 per cent. This fact as well as two other features of that group i.e. cases with long lasting S CF activity and occasional virus isolation several months after the initial acute infection, suggest that influenza virus might cause prolonged infection in some patients with chronic bronchitis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6860147     DOI: 10.1007/bf01315700

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  6 in total

1.  Preparation and characterization of influenza virus cores.

Authors:  M Reginster; M V Nermut
Journal:  J Gen Virol       Date:  1976-05       Impact factor: 3.891

2.  Ligands for antibody to M-protein are exposed at the surface of influenza virions: effect of proteolytic treatment on their activity.

Authors:  M Reginster; L Joassin; P Fontaine-Delcambe
Journal:  J Gen Virol       Date:  1979-11       Impact factor: 3.891

3.  Formation of antibody to matrix protein in experimental human influenza A virus infections.

Authors:  L Cretescu; A S Beare; G C Schild
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

4.  Application of the single radial diffusion test for assay of antibody to influenza type A viruses.

Authors:  S R Mostow; G C Schild; W R Dowdle; R J Wood
Journal:  J Clin Microbiol       Date:  1975-12       Impact factor: 5.948

5.  Matrix protein from influenza A virus and its role in cross-protection in mice.

Authors:  R G Webster; V S Hinshaw
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

  6 in total
  3 in total

Review 1.  The human antibody response to influenza A virus infection and vaccination.

Authors:  Florian Krammer
Journal:  Nat Rev Immunol       Date:  2019-06       Impact factor: 53.106

Review 2.  B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat.

Authors:  Jenna J Guthmiller; Henry A Utset; Patrick C Wilson
Journal:  Viruses       Date:  2021-05-22       Impact factor: 5.048

3.  Use of recombinant nucleoproteins in enzyme-linked immunosorbent assays for detection of virus-specific immunoglobulin A (IgA) and IgG antibodies in influenza virus A- or B-infected patients.

Authors:  J T Voeten; J Groen; D van Alphen; E C Claas; R de Groot; A D Osterhaus; G F Rimmelzwaan
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.